Hylek E - Search Results

1

Stroke prevention in elderly patients with atrial fibrillation.

Garcia D, Hylek E. Garcia D, et al. Among authors: hylek e. Lancet. 2007 Aug 11;370(9586):460-1. doi: 10.1016/S0140-6736(07)61208-2. Lancet. 2007. PMID: 17693158 No abstract available.

2

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population.

Garcia D, Regan S, Crowther M, Hughes RA, Hylek EM. Garcia D, et al. Chest. 2005 Jun;127(6):2049-56. doi: 10.1378/chest.127.6.2049. Chest. 2005. PMID: 15947319

3

Antithrombotic therapy in atrial fibrillation.

Garcia DA, Hylek EM. Garcia DA, et al. Clin Geriatr Med. 2006 Feb;22(1):155-66, x. doi: 10.1016/j.cger.2005.09.011. Clin Geriatr Med. 2006. PMID: 16377472 Review.

4

The risk of hemorrhage among patients with warfarin-associated coagulopathy.

Garcia DA, Regan S, Crowther M, Hylek EM. Garcia DA, et al. J Am Coll Cardiol. 2006 Feb 21;47(4):804-8. doi: 10.1016/j.jacc.2005.09.058. Epub 2006 Jan 26. J Am Coll Cardiol. 2006. PMID: 16487849 Free article.

5

A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.

Garcia D, Hylek E. Garcia D, et al. Among authors: hylek e. ACP J Club. 2007 Mar-Apr;146(2):52. ACP J Club. 2007. PMID: 17335175 No abstract available.

6

A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.

Garcia D, Hylek E. Garcia D, et al. Among authors: hylek e. Evid Based Med. 2007 Apr;12(2):57. doi: 10.1136/ebm.12.2.57. Evid Based Med. 2007. PMID: 17400649 No abstract available.

7

Risk of thromboembolism with short-term interruption of warfarin therapy.

Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM. Garcia DA, et al. Among authors: hylek em. Arch Intern Med. 2008 Jan 14;168(1):63-9. doi: 10.1001/archinternmed.2007.23. Arch Intern Med. 2008. PMID: 18195197

8

Reducing the risk for stroke in patients who have atrial fibrillation.

Garcia DA, Hylek E. Garcia DA, et al. Among authors: hylek e. Cardiol Clin. 2008 May;26(2):267-75, vii. doi: 10.1016/j.ccl.2007.12.011. Cardiol Clin. 2008. PMID: 18406999 Review.

9

Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.

Garcia DA, Witt DM, Hylek E, Wittkowsky AK, Nutescu EA, Jacobson A, Moll S, Merli GJ, Crowther M, Earl L, Becker RC, Oertel L, Jaffer A, Ansell JE; Anticoagulation Forum. Garcia DA, et al. Among authors: hylek e. Ann Pharmacother. 2008 Jul;42(7):979-88. doi: 10.1345/aph.1L098. Epub 2008 Jun 17. Ann Pharmacother. 2008. PMID: 18559954

10

Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.

Hylek EM. Hylek EM. Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343. Thromb Haemost. 2008. PMID: 18612532 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters